Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
Might be out of date by a couple months but covers most key points.
Already doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.
Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.
Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.
New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.
Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.
3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.
Have a 3 year development Remote Automated Water Research project for RAWTest.
Launch of ecowaterOS for real-time water monitoring, recovery, treatment and recycling. Some consortium members include Rinocloud AI, Modern Water (MWG), Acumen Software etc. A material contribution on revenue is already expected this year with partnership with Acumen Software.
I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.
Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.
Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.
May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.
Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound companies.
Pilgrim. Good point.
Have invested in Integumen for approx 18months and nothing has changed yet.
Its aim. Hope is needed for the majority of investments.
Confident and hope can go together but don’t waste time on my choice of words.
Moneyman. I didn’t expect fireworks from 2019 but I do expect more from H1 2020 onwards. Honeymoon period is over. I am confident going forward and the picture will become clearer (i hope)
Have revenues of 2 mill already only in Q1 and Gerard would have secured a larger loan Facility if he thought he’d need it. Also we don’t know the rev generated in Q2 so in terms of cash should be ok in my opinion. Will be clearer when we have the next results which having a look at last years RNS’s may be in September.
Haha now Bid increased and can sell at 1.88. MMs need them sellers.
Most of this morning and can sell 1.5 mill in one go. Some accumulation going on in background. Seems a new base if 1.80-1.90 being formed.
Summary of what has been achieved so far:
Already doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.
Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.
Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.
New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.
Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.
3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.
Have a 3 year development Remote Automated Water Research project for RAWTest.
Launch of ecowaterOS for real-time water monitoring, recovery, treatment and recycling. Some consortium members include Rinocloud AI, Modern Water (MWG), Acumen Software etc. A material contribution on revenue is already expected this year with partnership with Acumen Software.
I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.
Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.
Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.
May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.
Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Bi
Pilgrim agree with that. Integumen is a growth company so sit back and look at the Fundamentals getting stronger.
Have just under 58k myself which iv sat on for over a year now. Only think that has changed is the Fundamentals for the better. Gla
There is also a buyer in background. Can sell 1.5 mill shres in one go.
strange but buy at 1.785 and sell 1.80 on the nose using HL.
Already doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.
Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.
Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.
New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.
Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.
3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.
Have a 3 year development Remote Automated Water Research project for RAWTest.
Launch of ecowaterOS for real-time water monitoring, recovery, treatment and recycling. Some consortium members include Rinocloud AI, Modern Water (MWG), Acumen Software etc. A material contribution on revenue is already expected this year with partnership with Acumen Software.
I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.
Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.
Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.
May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.
Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound companies.
Worth a read for an over view. From jan 2020
https://www.turnerpope.com/wp-content/uploads/2020/02/Integumen_INITIATION_FINAL-09.01.2020.pdf
Will it hold 2p is the question. Really hope it does this time.
*not a must
Yazo not really. Prob do well to hold both but definitely a must. I am guessing you hold both
Good to see decent rounded buys last few says. May it continue.
My bad. No way would be net margin - Slip up.
Chesh - Full year 2019 should come end of June so we may find out about profitability before then
Frank - MWG has 1/2 amount of shares and a lower mcap hence why there was more value yet to be instilled.
Prefer SKIN to rise slowly instead of spiking and as some have mentioned, some do not realise how important Integumen is to MWG. Arguably MWG is more dependant on Integumen. The reason I say that it is because Integumen has many strings to its bow and the ability to make Revenue from Labskin, PTY, Rinocloud etc. Also our net margin is over 80%.
Keep repeating this but maybe worth a read to some new investors or those looking at SKIN to invest.
With Interims to become and us piggy backing off MWG revs. Well works both ways I guess its a win win situation.
Any good news on MWG is good for us. Compound growth is where we are at. Held for over a year and not letting go that easily. Only the start. GB is doing what he does best.
I wont put targets on the SP and keep them in my head for now :)